Shares ofNurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia.

Nurix Therapeutics shares jumped 12.1% to $17.01 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) rose 89.4% to $6.61 in pre-market trading after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity.
• Interactive Strength Inc. (NASDAQ:TRNR) shares rose...